Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen - Takeaways - MDSpire

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

  • By

  • Bingxin Cai

  • Yishan Wang

  • Wen Ma

  • Zhenzhen Wu

  • Tingting Yao

  • Pei Liu

  • Linhai Wang

  • Pingping Zhou

  • Yilin Li

  • May 29, 2026

  • 0 min

Share

  • 1

    The study evaluated CDO1/CELF4 methylation testing for detecting endometrial intraepithelial neoplasia and endometrial cancer.

  • 2

    A total of 226 women participated, with 31 diagnosed with endometrial intraepithelial neoplasia or endometrial cancer.

  • 3

    CDO1 and CELF4 methylation tests showed superior diagnostic capabilities compared to conventional markers.

  • 4

    There was a strong positive correlation between cervical brushing cells and D&C samples for methylation tests.

  • 5

    The CISENDO test demonstrated high sensitivity and specificity, with no significant difference in efficacy between sample types.

Original Source(s)

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

  • by Bingxin Cai, Yishan Wang, Wen Ma, Zhenzhen Wu, Tingting Yao, Pei Liu, Linhai Wang, Pingping Zhou, Yilin Li

  • May 29, 2026

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026